Ethical Considerations and Risks in Psychiatric Genetics: Preliminary Findings of a Study on Psychiatric Genetic Researchers

Jessica A. Erickson, M. Cho
{"title":"Ethical Considerations and Risks in Psychiatric Genetics: Preliminary Findings of a Study on Psychiatric Genetic Researchers","authors":"Jessica A. Erickson, M. Cho","doi":"10.1080/21507716.2011.628958","DOIUrl":null,"url":null,"abstract":"Background: There are high expectations for genetic research on psychiatric disorders. In addition to anticipating potential benefits, it is important to be aware of risks and ethical concerns. Previous studies have explored attitudes of various stakeholder groups toward psychiatric genetics research and testing. This study focuses on potential risks and ethical concerns as perceived by a hitherto untargeted stakeholder group: psychiatric genetic researchers. Methods: Thirty experts in psychiatric genetic research on schizophrenia, bipolar disorder (BP), and/or major depressive disorder (MDD) were interviewed and asked about their current research. Questions dealt with researchers’ beliefs about potential benefits, harms, and ethical concerns that could result from their work, as well as suggestions to ethically implement their research into clinical practice. Results: Respondents mainly discussed six ethical issues: (1) stigma; (2) prenatal testing and eugenics; (3) ethics of genetics research; (4) lack of genetic risk education among the general public and health care professionals; (5) premature commercialization and direct-to-consumer testing; and (6) lack of criteria for when to utilize psychiatric genetic tests. Bipolar and MDD genetic researchers were somewhat more likely to include moral arguments against psychiatric prenatal testing in their responses than schizophrenia researchers. Non-U.S. respondents were more likely to mention social discrimination concerns than U.S. respondents. Conclusions: Psychiatric genetic researchers’ viewpoints contribute a knowledgeable perspective about the capabilities and risks of psychiatric genetics research. Researchers were concerned that expectations of genetics precede the availability of valid and reliable psychiatric genetic tests. Psychiatric genetic researchers insisted that clinical validity is still a long way away and that making important life decisions based on current data poses a significant danger.","PeriodicalId":89316,"journal":{"name":"AJOB primary research","volume":"21 1","pages":"52 - 60"},"PeriodicalIF":0.0000,"publicationDate":"2011-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"AJOB primary research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/21507716.2011.628958","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 11

Abstract

Background: There are high expectations for genetic research on psychiatric disorders. In addition to anticipating potential benefits, it is important to be aware of risks and ethical concerns. Previous studies have explored attitudes of various stakeholder groups toward psychiatric genetics research and testing. This study focuses on potential risks and ethical concerns as perceived by a hitherto untargeted stakeholder group: psychiatric genetic researchers. Methods: Thirty experts in psychiatric genetic research on schizophrenia, bipolar disorder (BP), and/or major depressive disorder (MDD) were interviewed and asked about their current research. Questions dealt with researchers’ beliefs about potential benefits, harms, and ethical concerns that could result from their work, as well as suggestions to ethically implement their research into clinical practice. Results: Respondents mainly discussed six ethical issues: (1) stigma; (2) prenatal testing and eugenics; (3) ethics of genetics research; (4) lack of genetic risk education among the general public and health care professionals; (5) premature commercialization and direct-to-consumer testing; and (6) lack of criteria for when to utilize psychiatric genetic tests. Bipolar and MDD genetic researchers were somewhat more likely to include moral arguments against psychiatric prenatal testing in their responses than schizophrenia researchers. Non-U.S. respondents were more likely to mention social discrimination concerns than U.S. respondents. Conclusions: Psychiatric genetic researchers’ viewpoints contribute a knowledgeable perspective about the capabilities and risks of psychiatric genetics research. Researchers were concerned that expectations of genetics precede the availability of valid and reliable psychiatric genetic tests. Psychiatric genetic researchers insisted that clinical validity is still a long way away and that making important life decisions based on current data poses a significant danger.
精神病学遗传学的伦理考虑和风险:一项对精神病学遗传学研究人员的初步研究结果
背景:人们对精神疾病的基因研究寄予了很高的期望。除了预测潜在的好处,重要的是要意识到风险和道德问题。以往的研究已经探讨了不同利益相关者群体对精神病学遗传学研究和测试的态度。这项研究的重点是潜在的风险和伦理问题,因为迄今为止没有目标的利益相关者群体:精神病学基因研究人员。方法:对30位精神分裂症、双相情感障碍(BP)和/或重度抑郁症(MDD)的精神病学基因研究专家进行访谈,并询问他们目前的研究情况。问题涉及研究人员对其工作可能产生的潜在利益、危害和伦理问题的看法,以及在伦理上将其研究应用于临床实践的建议。结果:受访者主要讨论了6个伦理问题:(1)污名化;(2)产前检测和优生;(3)遗传学研究伦理;(4)公众和卫生保健专业人员缺乏遗传风险教育;(5)过早商业化和直接面向消费者的测试;(6)缺乏何时使用精神病学基因检测的标准。与精神分裂症研究人员相比,双相情感障碍和重度抑郁症基因研究人员更有可能在他们的回答中加入反对精神病学产前检测的道德论点。美国。受访者比美国受访者更有可能提到社会歧视问题。结论:精神病学遗传学研究人员的观点为精神病学遗传学研究的能力和风险提供了知识视角。研究人员担心,对遗传学的期望先于有效可靠的精神病学基因测试的可用性。精神病学基因研究人员坚持认为,临床有效性还有很长的路要走,根据目前的数据做出重要的人生决定会带来很大的危险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信